Literature DB >> 10785581

Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS).

C Lançon1, P Auquier, G Nayt, G Reine.   

Abstract

The main objective of the study was to verify the stability of the five-factor (negative. positive, excitation, depression and cognitive) structure of the Positive and Negative Syndrome Scale (PANSS). The psychometric properties (validity and reliability) of the forced five-factor structure of the PANSS were explored in two different populations of schizophrenic patients: one in relapse and the other in the chronic phase of the disease. Three hundred and forty-two schizophrenic patients according to DSM-III-R criteria were involved. One hundred and eighteen (34.5%) patients were in relapse, and 224 (65.5%) were in the chronic phase. The forced five-factor principal-component analysis explained 64.3% of the total variance in the relapse patients and 62.1% in the chronic patients. The order of the factors was reversed for the depression and excitation factors in chronic patients compared with patients in relapse. The internal consistency of this five-factor structure was good (Cronbach's alpha >0.70) in the relapse and chronic patients, except for the cognitive factor. In conclusion. five dimensions (negative, positive, excitation, depression and cognition) are necessary to account for the various clinical aspects of schizophrenia described by PANSS in relapse and chronic schizophrenic patients.

Entities:  

Mesh:

Year:  2000        PMID: 10785581     DOI: 10.1016/s0920-9964(99)00129-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  44 in total

1.  Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness.

Authors:  Piotr J Quee; Lisette van der Meer; Richard Bruggeman; Lieuwe de Haan; Lydia Krabbendam; Wiepke Cahn; Niels C L Mulder; Durk Wiersma; André Aleman
Journal:  Schizophr Bull       Date:  2010-11-22       Impact factor: 9.306

2.  Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis.

Authors:  Todd S Woodward; Kwanghee Jung; Geoffrey N Smith; Heungsun Hwang; Alasdair M Barr; Ric M Procyshyn; Sean W Flynn; Mark van der Gaag; William G Honer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-15       Impact factor: 5.270

3.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

4.  Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?

Authors:  Ariana Anderson; Marsha Wilcox; Adam Savitz; Hearee Chung; Qingqin Li; Giacomo Salvadore; Dai Wang; Isaac Nuamah; Steven P Riese; Robert M Bilder
Journal:  Psychiatry Res       Date:  2015-01-06       Impact factor: 3.222

5.  A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.

Authors:  Christian Schmidt-Kraepelin; Sandra Feyerabend; Christina Engelke; Mathias Riesbeck; Eva Meisenzahl-Lechner; Wolfgang Gaebel; Pablo-Emilio Verde; Henrike Kolbe; Christoph U Correll; Stefan Leucht; Stephan Heres; Michael Kluge; Christian Makiol; Andrea Neff; Christina Lange; Susanne Englisch; Mathias Zink; Berthold Langguth; Timm Poeppl; Dirk Reske; Euphrosyne Gouzoulis-Mayfrank; Gerhard Gründer; Alkomiet Hasan; Anke Brockhaus-Dumke; Markus Jäger; Jessica Baumgärtner; Thomas Wobrock; Joachim Cordes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-09-05       Impact factor: 5.270

Review 6.  Management of negative symptoms of schizophrenia.

Authors:  D C Javitt
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

7.  Event-related potential and time-frequency endophenotypes for schizophrenia and psychotic bipolar disorder.

Authors:  Lauren E Ethridge; Jordan P Hamm; Godfrey D Pearlson; Carol A Tamminga; John A Sweeney; Matcheri S Keshavan; Brett A Clementz
Journal:  Biol Psychiatry       Date:  2014-05-04       Impact factor: 13.382

8.  Neural correlates of out-group bias predict social impairment in patients with schizophrenia.

Authors:  J U Blackford; L E Williams; S Heckers
Journal:  Schizophr Res       Date:  2015-04-09       Impact factor: 4.939

9.  Abnormal asymmetry of white matter integrity in schizophrenia revealed by voxelwise diffusion tensor imaging.

Authors:  Jun Miyata; Akihiko Sasamoto; Katja Koelkebeck; Kazuyuki Hirao; Keita Ueda; Ryosaku Kawada; Shinsuke Fujimoto; Yusuke Tanaka; Manabu Kubota; Hidenao Fukuyama; Nobukatsu Sawamoto; Hidehiko Takahashi; Toshiya Murai
Journal:  Hum Brain Mapp       Date:  2011-10-05       Impact factor: 5.038

10.  Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.

Authors:  Milena Y Gotra; Scot K Hill; Elliot S Gershon; Carol A Tamminga; Elena I Ivleva; Godfrey D Pearlson; Matcheri S Keshavan; Brett A Clementz; Jennifer E McDowell; Peter F Buckley; John A Sweeney; Sarah K Keedy
Journal:  Schizophr Res       Date:  2020-07-14       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.